Małecka-Massalska Teresa, Chara Krzysztof, Gołębiowski Paweł, Władysiuk Magdalena, Smoleń Agata, Kurylcio Andrzej, Zuchora Beata, Zubrzycki Jarosław, Orłowska-Kowalik Grażyna, Lupa-Zatwarnicka Krystyna, Polkowski Wojciech
Department of Physiology, Medical University, Lublin, Poland.
Ann Agric Environ Med. 2013;20(3):523-7.
In the United States, breast cancer (BC) is the most common non-skin cancer. In Poland, it is estimated that the number of new breast cancer cases affects about 13,500 women each year. There are many methods for nutritional status assessment. One of them is bioimpedance analysis (BIA). Direct bioimpedance measures (resistance, reactance, phase angle (PA)) determined by bioelectrical impedance analysis (BIA) detectf changes in tissue electrical properties. The study was conducted to investigate whether there are any tissue electrical differences in patients with breast cancer.
The direct bioimpedance measures determined by bioelectrical impedance analysis (BIA) were performed on 34 patients with BC and 34 healthy volunteers. The measurements were made with ImpediMed bioimpedance analysis SFB7 BioImp v1.55 (Pinkenba Qld 4008, Australia).
Reactance and resistance at 50 kHz was found to be significantly greater in patients with BC than in the control group (53.59° ± 1.53 vs. 47.26° ± 1.25, respectively, p=0.0031; 603.24° ± 15.38 ohm vs. 515.87° ± 11.48 ohm, respectively, p=0.00004).
Pre-surgical patients diagnosed with BC have altered tissue electrical properties. Further observations of a larger patient group would be valuable to calculate survival, validate the prognostic significance of PA, and monitor nutritional and therapeutic interventions in this patient population.
在美国,乳腺癌(BC)是最常见的非皮肤癌。在波兰,据估计每年新确诊的乳腺癌病例约影响13500名女性。营养状况评估有多种方法。其中之一是生物电阻抗分析(BIA)。通过生物电阻抗分析(BIA)测定的直接生物阻抗测量值(电阻、电抗、相位角(PA))可检测组织电学特性的变化。本研究旨在调查乳腺癌患者是否存在组织电学差异。
对34例乳腺癌患者和34名健康志愿者进行了通过生物电阻抗分析(BIA)测定的直接生物阻抗测量。测量使用ImpediMed生物阻抗分析仪SFB7 BioImp v1.55(澳大利亚昆士兰州平肯巴4008)进行。
发现乳腺癌患者在50kHz时的电抗和电阻显著高于对照组(分别为53.59°±1.53与47.26°±1.25,p = 0.0031;603.24°±15.38欧姆与515.87°±11.48欧姆,p = 0.00004)。
术前被诊断为乳腺癌的患者组织电学特性发生了改变。对更大患者群体的进一步观察对于计算生存率、验证PA的预后意义以及监测该患者群体的营养和治疗干预将具有重要价值。